Cristoforo Mione

Angel Investor · Milan, Italy

Invests in AI

Cristoforo Mione's investor profile lists AI alongside Healthcare & Biotech and Media & Content, at early-stage venture. The record holds 2 deals, among them DoctorBase (Healthcare Technology Systems) and Matchmade.

Email Investor

Email Investor

Credits to line up before an early-stage round

Cristoforo Mione backs companies at early-stage venture. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • DoctorBase (Healthcare Technology Systems)
  • Matchmade

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, Media & Content
Rounds
Early-stage venture
Profile
Angel investor
Deals on record
2
Based in
Milan, Italy

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Cristoforo Mione invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Cristoforo Mione's investor profile, together with Healthcare & Biotech and Media & Content. The stages on record are early-stage venture.
Which companies has Cristoforo Mione backed?
The record lists 2 deals, including DoctorBase (Healthcare Technology Systems) and Matchmade. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Cristoforo Mione?
For a company raising an early-stage round, AI Perks lists credits such as Alibaba Cloud (up to Up to $120,000 + 2B Model Studio tokens), AssemblyAI (up to $150,000), Redis (up to $10,000) and Algolia (up to $10,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor